Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2014 04:00 ET | Source: MannKind

MannKind Updates Status of New Drug Application for AFREZZA(R)

VALENCIA, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act...
April 01, 2014 17:47 ET | Source: MannKind

FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes

VALENCIA, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug...
February 19, 2014 08:00 ET | Source: MannKind

MannKind Corporation to Present at Upcoming Conferences

VALENCIA, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...
February 18, 2014 08:00 ET | Source: MannKind

MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results

VALENCIA, Calif., Feb. 18, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2013. For the fourth...
February 04, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014

VALENCIA, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2013 fourth quarter and full year financial results on Tuesday, February 18, 2014 and its...
January 10, 2014 06:00 ET | Source: MannKind

MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA

VALENCIA, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug...
January 08, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference

VALENCIA, Calif., Jan. 8, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...